NOVOZYMES A/S SPONS.ADR 1 (NZM) — Financial Flexibility Index
NOVOZYMES A/S SPONS.ADR 1 (NZM) has a Financial Flexibility Index of 0.05x as of March 2026. Free cash flow of €260.20 Million (operating CF €167.10 Million minus capex €93.10 Million) represents 0% of total liabilities (€5.60 Billion). Also explore NZM net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
NOVOZYMES A/S SPONS.ADR 1 Financial Flexibility Index (2021–2025)
Historical Financial Flexibility Index trend for NOVOZYMES A/S SPONS.ADR 1 across 5 annual periods. Check NZM asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Annual Financial Flexibility Index for NOVOZYMES A/S SPONS.ADR 1 (2021–2025)
Year-by-year free cash flow to debt coverage for NOVOZYMES A/S SPONS.ADR 1. For the full company profile including market capitalisation, see NOVOZYMES A/S SPONS.ADR 1 (NZM) total market value.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.31x | €1.69 Billion | €1.22 Billion | €5.49 Billion | ▼ -10.3% |
| 2024 | 0.34x | €1.38 Billion | €1.02 Billion | €4.02 Billion | ▼ -22.4% |
| 2023 | 0.44x | €832.90 Million | €557.10 Million | €1.88 Billion | ▼ -11.8% |
| 2022 | 0.50x | €925.52 Million | €537.65 Million | €1.85 Billion | ▲ +18.8% |
| 2021 | 0.42x | €712.90 Million | €546.17 Million | €1.69 Billion | — |